TrialAntimicrobial agents and chemotherapy2013

Characterization of Hepatitis C virus resistance from a multiple-dose clinical trial of the novel NS5A inhibitor GS-5885.

Kelly A Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.